Novartis Corporation
608 5th Avenue
New York
New York
10020
United States
Tel: 212-307-1122
Fax: 212-246-0185
Website: http://www.us.novartis.com/
443 articles about Novartis Corporation
-
Novartis Corporation Breakthrough Therapy LDK378 Shows a Marked Clinical Response in Patients With ALK+ Non-Small Cell Lung Cancer
6/3/2013
-
Novartis Corporation Release: 8 Scottish Life Science Companies Descend Upon Boston in Search of Investors and Partners
6/15/2012
-
Novartis Corporation Sits in the Penalty Box
4/25/2012
-
FDA Approves Novartis Corporation's Gleevec for Expanded Use in Patients With Rare Gastrointestinal Cancer
2/1/2012
-
Endo Pharmaceuticals Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis CorporationFacility
1/9/2012
-
Novartis Corporation Pivotal Study of Exjade(R) Shows Significant Reduction of Iron Overload in Patients with Non-transfusion-dependent Thalassemia
12/13/2011
-
Novartis Corporation Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis
11/7/2011
-
Viamet Pharmaceuticals Appoints Former Novartis Corporation Executive Marc Rudoltz, M.D. as Chief Medical Officer
11/3/2011
-
Novartis Corporation Release: IBM Corporation Launches University Competition to Combat Growth of Non-Communicable Diseases
10/10/2011
-
Novartis AG Receives Approval in Japan for Two Innovative Therapies, Gilenya(R) in MS and Ilaris(R) in CAPS
9/27/2011
-
Novartis Corporation Associates Participate in First Company-Wide Health and Well-Being Initiative
9/19/2011
-
Novartis Corporation Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
9/16/2011
-
Novartis Corporation Med Gets EU OK for Benign Brain Tumors
9/9/2011
-
FDA: Novartis Corporation's Osteoporosis Drug Reclast Raises Kidney Failure Risk
9/6/2011
-
Novartis Corporation' Generics Firm's Edge
9/2/2011
-
Vectura Group plc Expands COPD/Asthma Drug Pact With Novartis Corporation
8/8/2011
-
Zacks Bull and Bear of the Day Highlights: Brightpoint, Medtronic, Inc., Amgen, Novartis Corporation and GlaxoSmithKline
7/19/2011
-
Humira to Assume Lipitor's Crown as Pfizer Inc. Feels the Heat From Sanofi (France) and Novartis Corporation
6/28/2011
-
At Novartis Corporation, Pensions are Out and Cash-Grabbing is in
6/24/2011
-
Novartis Corporation Drug Gives Pain Relief in Gouty Arthritis in Two Phase III Trials
5/26/2011